-- ファルコン・コンセプツ（BOM：544164）は、トゥシュティ・ホームズから420万インドルピー相当の新規受注を獲得した。これは火曜日にボンベイ証券取引所（BSE）に提出された書類で明らかになった。 この契約は、インドのグルグラムにあるトゥシュティ・ホームズのプロジェクト「ザ・ベレア」向けに、ガラス、グレージング、窓を供給するものである。 プロジェクトは2ヶ月以内に完了する予定だ。 同社の株価は直近の取引で約3%下落した。
Related Articles
Research
Research Alert: CFRA Keeps A Hold View On Shares Of Meritage Homes Corporation
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month target price of $73, calculated using a 11.5x multiple against our 2027 EPS view of $6.37. Our multiple is a premium to the 10-year forward P/E mean of 7.9x, reflecting MTH's 60-day closing strategy that has the potential to move volumes in a normalized environment. We revise our 2026 EPS view to $4.96, down from $6.61 and 2027 revised to $6.37 from $8.08. We expect elevated incentives will keep a lid on MTH's margins, while a competitive landscape limits significant market share gains. MTH's primary growth driver, an aggressive expansion in community count, helps offset slower per-store sales but adds its own pressures in a limited demand environment. However, MTH trades at a 20% discount to book value, reinforced by MTH's share repurchase program, providing downside support for shares. While we expect Q2 to benefit from favorable comps, we would like to see tangible improvement in housing demand in 2H 2026 before becoming more bullish on shares.
$MTH
Research
Research Alert: CFRA Keeps Sell Opinion On Shares Of Ggg
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target to $70 from $80, valuing shares at 21x our 2027 EPS outlook of $3.36 (down from $3.46; 2026 EPS estimate revised to $3.10 from $3.18), a discount to GGG's historical multiple average given high uncertainty around a sustained recovery in the housing market. GGG's Q1 print was disappointing, with organic revenues declining amid broad-based weakness across most geographies, particularly in Asia-Pacific. While acquisitions provided some offset to total sales growth, all three segments experienced organic revenue headwinds, with profitability deteriorating. GGG continues to navigate a challenging operating environment given soft residential markets. Pricing continues to prop results up, though ongoing volume decline will continue to limit upside, in our view. Industrial orders were a bright spot in Q1 given an expanding manufacturing base in the U.S., though the downtrend in the Contractor business will need to stabilize to not offset the emerging demand pick-up.
$GGG
Insider Trading
Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing
Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml
$LFST